8-K: Aethlon Medical Implements 1-for-5 Reverse Stock Split

Aethlon Medical, Inc. announced a 1-for-5 reverse stock split to manage dilution and maintain Nasdaq compliance, effective July 31, 2026.

Summary

• Aethlon Medical, Inc. has filed a Certificate of Change to enact a 1-for-5 reverse stock split of its common stock.
• This reverse stock split is part of the company's capital markets and operating plan, aimed at managing dilution and ensuring continued compliance with Nasdaq Listing Rule 5550(a)(2).
• The reverse stock split will become effective on July 31, 2026, at 10:00 a.m. Eastern Time.
• Trading on a split-adjusted basis is expected to commence on The Nasdaq Capital Market on August 4, 2026, under the existing symbol AEMD.
• No fractional shares will be issued; instead, any fractional share entitlement will be rounded up to the nearest whole share.
• The total authorized shares of common stock will decrease from 100,000,000 to 20,000,000.
• As of July 23, 2026, there were 3,249,569 shares outstanding, which will be approximately 649,914 shares post-split.
• Stockholder approval was not required for this action, as it was approved by the board of directors and complies with Nevada law.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral to slightly negative. While necessary for Nasdaq compliance and dilution management, reverse splits can sometimes be perceived as a sign of underlying weakness.

Positives

• Maintains compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price.
• Aims to manage equity dilution, potentially making the stock more attractive to institutional investors.
• Simplifies the share structure by reducing the number of outstanding shares.
• No cash is paid for fractional shares, and fractional entitlements are rounded up to whole shares, preserving shareholder equity.

Negatives

• A reverse stock split can sometimes be perceived negatively by the market, potentially signaling underlying financial challenges.
• The number of outstanding shares will significantly decrease, which may not be favorable for all investors.
• The CUSIP number will change, requiring updates for some record-keeping systems.

Risks

• Continued compliance with Nasdaq Listing Rule 5550(a)(2) is a stated reason, implying the stock price may have been at risk of delisting.
• The need to manage dilution suggests potential ongoing capital needs or past dilutive events.

Future Outlook

The reverse stock split is part of an overall capital-markets and operating plan. The company expects to trade on a split-adjusted basis on Nasdaq starting August 4, 2026.

Industry Context

StockSavvy.ai notes that reverse stock splits are often undertaken by companies facing challenges in maintaining minimum bid price requirements for exchange listing, or to reduce share count for strategic reasons. This action by Aethlon Medical suggests a focus on meeting Nasdaq's listing standards and potentially improving investor perception by reducing share count.

Stakeholder Impact

• Shareholders will hold fewer shares, but their percentage ownership and voting power will remain largely the same, except for minor adjustments due to rounding of fractional shares.
• Brokers and transfer agents will need to update their systems to reflect the split-adjusted share counts and new CUSIP number.

Next Steps

• Shares will begin trading on a split-adjusted basis on The Nasdaq Capital Market on August 4, 2026.
• The CUSIP number for the Common Stock will change to 00808Y703.

Key Dates

Recommendation

The filing is a procedural corporate action (reverse stock split) necessary for Nasdaq compliance and dilution management. It does not provide new financial performance data or strategic breakthroughs. While it addresses potential delisting risks, it doesn't inherently improve the company's fundamental business prospects, thus a 'hold' recommendation is appropriate pending further operational or financial updates.

Keywords

Reverse Stock Split, Nasdaq Compliance, Dilution Management, Common Stock, Capital Markets, Nevada Corporation, Shareholder Equity